CRT 2025
Valve and Structural
Hot Topics in Structural
Rahul Prakash Sharma, MD
Director of Structural Interventions
Stanford Healtchare
Palo Alto, California, United States
Disclosure(s): Abbott Cardiovascular Systems: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Maurice Buchbinder, MD, FSCAI
Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States
Disclosure(s): No financial relationships to disclose
Michael J. Reardon, MD
Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States
Disclosure(s): BSCI: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); High Life: Consulting Fees (e.g., advisory boards) (Ongoing); JValve: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Steven F. Bolling, MD
Professor of Cardiac Surgery
University of Michigan Hospital
Ann Arbor, Michigan, United States
Disclosure(s): Tangent: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); xDOT: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Eberhard Grube, MD, MSCAI
Head CIIC
University Hospital Bonn
Bonn, Nordrhein-Westfalen, Germany
Disclosure information not submitted.
Paul D. Mahoney, MD, FACC, FSCAI
Chief, Interventional Cardiology, Director, Structural Heart Program
ECU Health
Greenville, North Carolina, United States
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Clinical Proctor (Ongoing), Consultant (Ongoing)
Augusto Pichard, MD, FACC, MSCAI, FSFC
Interventional cardiologist
MEDSTAR Washington Hospital Center
Washington, District of Columbia, United States
Disclosure(s): No financial relationships to disclose
Toby Rogers, MD, PhD
Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)
Moritz C. Wyler von Ballmoos, MD, PhD, MPH
System Chair of Cardiac & Thoracic Surgery
Texas Health Resources & TCU
Fort Worth, Texas, United States
Disclosure(s): No financial relationships to disclose